Medicare Enrolled
Dr. James Stocks, M.D.
Urology Physician · Cypress, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stocks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stocks?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stocks
Dr. James Stocks is an urology physician in Cypress, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Stocks performed 47,428 Medicare services across 2,926 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stocks received a total of $5,783 from 37 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stocks is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 1% volume in TX
$5,783 industry payments
Medicare Practice Summary
Medicare Utilization ↗47,428
Medicare services
Top 1% in TX for urology physician
2,926
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,388 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
37,328 | $0 | $0 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
3,094 | $34 | $68 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
1,596 | $34 | $88 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
761 | $3 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
746 | $102 | $395 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
716 | $34 | $81 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $64 | $257 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
399 | $68 | $175 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
351 | $34 | $81 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
349 | $34 | $77 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
297 | $8 | $38 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
252 | $11 | $73 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
141 | $34 | $87 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
137 | $34 | $87 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
133 | $34 | $88 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
119 | $63 | $238 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $128 | $516 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
61 | $192 | $718 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $104 | $400 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
47 | $629 | $2,383 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $63 | $323 |
| Complicated insertion of bladder tube | 24 | $118 | $458 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
15 | $538 | $4,434 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,783
Total received (2018-2024)
Avg $826/year across 7 years
Top 34% in TX for urology physician
37
Companies
187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,187 (89.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$596 (10.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,046
2023
$1,384
2022
$1,189
2021
$460
2020
$539
2019
$453
2018
$711
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$933
Coloplast Corp
$822
Myriad Genetic Laboratories, Inc.
$689
PROCEPT BioRobotics Corporation
$615
Endo Pharmaceuticals Inc.
$416
ConvaTec Inc.
$272
Boston Scientific Corporation
$227
Antares Pharma, Inc.
$213
Axonics, Inc.
$119
Agiliti Surgical, Inc.
$112
Endo USA, Inc.
$110
Intuitive Surgical, Inc.
$94
McKesson Medical-Surgical, Inc.
$94
PFIZER INC.
$91
Myovant Sciences Inc.
$81
UROVANT SCIENCES INC
$70
Hollister Incorporated
$69
COLOPLAST CORP
$64
AbbVie Inc.
$62
Olympus America Inc.
$54
Sumitomo Pharma America, Inc.
$51
Cook Medical LLC
$51
ABC Home Medical Supply, Inc.
$50
180 Medical, Inc.
$49
UroGen Pharma, Inc.
$48
Kowa Pharmaceuticals America, Inc.
$44
Medtronic, Inc.
$39
C. R. Bard, Inc. & Subsidiaries
$37
Ambu Inc.
$34
Mission Pharmacal Company
$32
Smith+Nephew, Inc.
$26
Silk Road Medical, Inc.
$22
Janssen Biotech, Inc.
$21
Pacira Pharmaceuticals Incorporated
$20
Acerus Pharmaceuticals Corporation
$19
UROGEN PHARMA, INC.
$17
BOSTON SCIENTIFIC CORPORATION
$17
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ALTIS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AQUACEL FOAM · AVEED · Altis · AquaBeam Robotic System · Axonics · BOTOX · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CURE CATHETER · CURE DEXTRA · Cook Medical Urology · Da Vinci Surgical System · ENROUTE Transcarotid Neuroprotection System · Exparel · FEMALE INCONTINENCE · GEMTESA · GENERAL BPH · GENERAL - BPH · GENTLECATH · GENTLECATH GLIDE · General - Kidney Stone Disease · INTERSTIM · Infyna Chic · JELMYTO · LITHOVUE · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · ORGOVYX · OTREXUP · Onli · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · REZUM · Rezum Generator · SEGLENTIS · SWISS LITHOCLAST TRILOGY · Seglentis · Sonablate HIFU · SpaceOAR VUE System - 10mL · SpeediCath · Stravix · TOVIAZ · Titan · URIBEL · Uribel · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
80
Per 100K population
1.7
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Stocks is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Stocks experienced with testosterone injection?
Based on Medicare claims data, Dr. Stocks performed 37,328 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stocks receive payments from pharmaceutical companies?
Yes. Dr. Stocks received a total of $5,783 from 37 companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stocks's costs compare to other urology physicians in Cypress?
Dr. Stocks's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stocks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cypress
Browse urology physicians in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology